Learn More
Invitrogen™ Human TAF8 (aa 18-79) Control Fragment Recombinant Protein
Description
Highest antigen sequence indentity to the following orthologs: Mouse (100%), Rat (100%). This recombinant protein control fragment may be used for blocking experiments with the corresponding antibody, PA5-56839 (PA5-56839. In IHC/ICC and WB experiments, we recommend a 100x molar excess of the protein fragment control based on the concentration and the molecular weight. Pre-incubate the antibody-protein control fragment mixture for 30 min at room temperature.
Specifications
Specifications
| Accession Number | Q7Z7C8 |
| Concentration | ≥5.0 mg/mL |
| For Use With (Application) | Blocking Assay, Control |
| Formulation | 1 M urea, PBS with no preservative; pH 7.4 |
| Gene ID (Entrez) | 129685 |
| Name | Human TAF8 (aa 18-79) Control Fragment |
| Quantity | 100 μL |
| Regulatory Status | RUO |
| Gene Alias | AW260255; hTAFII43; II; Protein taube nuss; Protein taube nuss-like; similar to taube nuss; TAF; TAF(II)43; TAF8; TAF8 RNA polymerase II, TATA box binding protein (TBP)-associated factor; TAF8 RNA polymerase II, TATA box binding protein (TBP)-associated factor, 43 kDa; TAF8 RNA polymerase II, TATA box binding protein (TBP)-associated factorq; TAFII43; TAFII-43; TATA box binding protein (TBP)-associated factor, RNA polymerase II, A, 45/50 kDa; TATA box binding protein associated factor 8; TATA-box binding protein associated factor 8; taube nuss; taube nuss homolog; TBN; tbnl; tbnl protein; TBP-associated factor 43 kDa; TBP-associated factor 8; TBP-associated factor TAFII43; TBP-associated factor, RNA polymerase II, 43 kD; transcription initiation factor TFIID 43 kDa subunit; Transcription initiation factor TFIID subunit 8; zgc:56401; zgc:77837 |
| Common Name | TAF8 |
| Show More |
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.